Status:
COMPLETED
Improving Medication Compliance and Smoking Cessation Treatment Outcomes for African American Smokers
Lead Sponsor:
Nikki Nollen, PhD, MA
Conditions:
Smokers
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Little is known about the support needed to improve compliance with Chantix for smoking cessation. This is a two arm pilot study of African American smokers to provide varying levels of side effect ma...
Eligibility Criteria
Inclusion
- African American
- 18-75 years of age
- Smoke more than 10 cigarettes per day
- Have a functioning telephone number
- Be interested in quitting smoking
- Be willing to take 3 months of Chantix
- Be willing to complete all study visits
Exclusion
- Renal impairment
- Evidence or history of clinically significant allergic reactions to Chantix
- Cardiovascular event in the past month
- History of alcohol or drug abuse/dependency in the past year
- Major depressive disorder in the last year requiring treatment
- History of panic disorder
- Psychosis, bipolar or eating disorder
- Use of antidepressants, antipsychotics, mood stabilizers/anticonvulsants or naltrexone
- Use of tobacco products other than cigarettes
- Use of nicotine replacement therapy, bupropion, clonidine or nortriptyline in the month prior to enrollment
- Prior use of Chantix
- Women who are pregnant, contemplating getting pregnant or breastfeeding
- Plans to move from Kansas City during the 3 month treatment phase
- Another household member enrolled in the study
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2010
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT00781599
Start Date
October 1 2008
End Date
March 1 2010
Last Update
July 11 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kansas Medical Center
Kansas City, Kansas, United States, 66160